Status:

COMPLETED

Appropriation of the Connected Solution Freestyle Libre® in Adult Patients With Diabetes in the Context of Therapeutic Education

Lead Sponsor:

Direction Centrale du Service de Santé des Armées

Conditions:

Diabetes

Eligibility:

All Genders

18+ years

Brief Summary

Following the proposal to self-monitor by the Freestyle Libre® (FSL) connected object, in diabetic patients in the context of therapeutic education, regarding the appropriation of FSL, what works, for...

Eligibility Criteria

Inclusion

  • Patients
  • Have type 1 or type 2 diabetes (as included in the education program),
  • Be of legal age (over 18 years old),
  • Do not present legal protection measures due to incapacity (such as guardianship or guardianship).
  • Be able to read and speak French (elementary school level)
  • Be eligible for FSL prescription and authorize the sharing of your data in Libreview®
  • Be affiliated to a social security scheme
  • Have an email address or a phone allowing internet use
  • Caregivers
  • Be registered on the roll of his professional order
  • Hold the certificate of 40 hours of training in therapeutic education.
  • Practice therapeutic education on a regular basis

Exclusion

  • Patients
  • presenting contraindications to the use of Freestyle Libre® (known allergies to adhesive products, coagulation disorders, not treated with insulin therapy or with less than 3 insulin injections per day or continuously, not requiring glycemic monitoring or less than 3 times a day)
  • Patient refusing to follow the education program,
  • Minors, patients under administrative or judicial supervision)
  • Pregnant women,
  • Patients who cannot be contacted in an emergency,
  • Persons in a position to give their consent but with an inability to read / write the French language.
  • Patients who do not have an email address or a phone allowing internet use.
  • Caregivers
  • Failure to register with the professional order (except those of the Army Health Service who are exempt)
  • Non-possession of the 40-hour therapeutic education training certificate.
  • Not practicing FSL education

Key Trial Info

Start Date :

June 10 2021

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

September 6 2023

Estimated Enrollment :

86 Patients enrolled

Trial Details

Trial ID

NCT04739124

Start Date

June 10 2021

End Date

September 6 2023

Last Update

September 21 2023

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Hôpital Avicenne

Bobigny, France, 93009

2

Hopital d'Instruction des Armées Bégin

Saint-Mandé, France, 94163